Trial intelligence / Profile preview

POPEYE: TJ-45 for prevention of postoperative delirium in elderly gastroenterological cancer surgery

jRCTs051180134Completed

Sponsor
The Supporting Center for Clinical Research and Education
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of yokukansan in postoperative delirium (POD) and gastrointestinal cancer (2 arms), sponsored by The Supporting Center for Clinical Research and Education. Primary endpoint: Incidence of postoperative delirium. Started Mar 2019; status: completed.

02

Drugs

yokukansan
03

Conditions

postoperative delirium (POD)gastrointestinal cancer

Beyond the preview

Go deeper on jRCTs051180134.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051180134.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call